Inventor
CZIRR EVA
US8 patents
Patents
8 patentsUS10357513B2Jul 23, 2019
Dosing regimen for treatment of cognitive and motor impairments with blood plasma and blood plasma products
ALKAHEST INC17 citations91
US10874692B2Dec 29, 2020
Dosing regimen for treatment of cognitive and motor impairments with blood plasma and blood plasma products
ALKAHEST INC6 citations81
US11413308B2Aug 16, 2022
Dosing regimen for treatment of cognitive and motor impairments with blood plasma and blood plasma products
ALKAHEST INC1 citations70
US11040068B2Jun 22, 2021
Dosing regimen for treatment of cognitive and motor impairments with blood plasma and blood plasma products
ALKAHEST INC1 citations59
US11426399B2Aug 30, 2022
Treatment of aging-associated disease with modulators of leukotriene A4 hydrolase
ALKAHEST INC1 citations57
US11344542B2May 31, 2022
Treatment of aging-associated disease with modulators of leukotriene A4 hydrolase
ALKAHEST INC0 citations57
US12496296B2Dec 16, 2025
Benzodioxane modulators of leukotriene A4 hydrolase (LTA4H) for prevention and treatment of aging-associated diseases
ALKAHEST INC0 citations54
US11957671B2Apr 16, 2024
Benzodioxane modulators of leukotriene A4 hydrolase (LTA4H) for prevention and treatment of aging-associated diseases
ALKAHEST INC1 citations54